Abstract
Lung cancer is the single most common cause of death, and almost all of it is due to tobacco smoking. Before the widespread use of cigarettes in this century, lung cancer was a rare illness. Tobacco smoke is a complex mixture of numerous mutagens and carcinogens. Over the last 40 years, the type of cigarettes most frequently used has been changing, namely the increased use of low tar and nicotine cigarettes. This has been accompanied by an increased risk of lung cancer due to a smokers' need to maintain blood nicotine levels, which in turn causes the need for smoking more cigarettes per day and deeper inhalation. This phenomena has led to the increasing rates of lung adenocarcinoma, compared to squamous cell carcinoma. It also probably explains, in part, the greater risk of lung cancer in women compared to men (in addition to some biological differences). The study of lung cancer involves many types of biomarkers, including those that measure exposure, the biologically effective dose and harm. The use of these has allowed us to understand many parts of lung carcinogenesis. Genetic susceptibilities play a large role in lung cancer risk. They govern smoking behavior (affecting dopamine reward mechanisms due to nicotine and nicotine metabolism), carcinogen metabolism and detoxification, DNA repair, cell cycle control and other cellular responses. The need for the study of lung cancer is highlighted by the need to improve cessation rates and reduce exposure among persons who cannot quit smoking, for better prevention strategies for former smokers and an understanding of environmental tobacco smoke risk.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Atawodi SE, Lea S, Nyberg F, Mukeria A, Constantinescu V, Ahrens W, Brueske-Hohlfeld I, Fortes C, Boffetta P, Friesen MD . 1998 Cancer Epidemiol. Biomarkers Prev. 7: 817–821
Auerbach O, Brewster G, Forman JB, Petrick TG, Smolin HJ, Meuhsam GE, Kassouny DY, Stout AP . 1957 New Engl. J. Med. 256: 97–104
Badawi AF, Hirvonen A, Bell DA, Lang NP, Kadlubar FF . 1995 Cancer Res. 55: 5230–5237
Bailar III JC . 1999 N. Engl. J. Med. 340: 958–959
Bardeesy N, Falkoff D, Petruzzi MJ, Nowak N, Zabel B, Adam M, Aguiar MC, Grundy P, Shows T, Pelletier J . 1994 Nat. Genet. 7: 91–97
Benowitz NL, Hall SM, Herning RI, Jacob III P, Jones RT, Osman AL . 1983 N. Engl. J. Med. 309: 139–142
Benowitz NL, Jacob III P, Kozlowski LT, Yu L . 1986b N. Engl. J. Med. 315: 1310–1313
Benowitz NL, Jacob III P, Yu L, Talcott R, Hall S, Jones RT . 1986a JAMA 256: 241–246
Benowitz NL, Zevin S, Jacob III P . 1998 J. Pharmacol. Exp. Ther. 287: 958–962
Brennan JA, Boyle JO, Koch WM, Goodman SN, Hruban RH, Eby YJ, Couch MJ, Forastiere AA, Sidransky D . 1995 N. Engl. J. Med. 332: 712–717
Brockmoller J, Cascorbi I, Kerb R, Sachse C, Roots I . 1998 Toxicol. Lett. 102–103: 173–183
Brownson RC, Alavanja MC, Caporaso N, Simoes EJ, Chang JC . 1998 Epidemiol. Rev. 20: 218–236
Brownson RC, Alavanja MC, Hock ET, Loy TS . 1992 Am. J. Public Health 82: 1525–1530
Brownson RC, Eriksen MP, Davis RM, Warner KE . 1997 Annu. Rev. Public Health 18: 163–185
Brunnemann KD, Prokopczyk B, Djordjevic MV, Hoffmann D . 1996 Crit. Rev. Toxicol. 26: 121–137
Burney LE . 1959 J. Am. Med. Assoc. 171: 1829–1837
Comings DE, Ferry L, Bradshaw-Robinson S, Burchette R, Chiu C, Muhleman D . 1996 Pharmacogenetics 6: 73–79
Cornfield J, Haenszel W, Hammond EC, Lilienfeld AM, Shimkin MB, Wynder EL . 1959 J. Natl. Cancer Inst. 22: 173–203
Darby SC, Pike MC . 1988 Br. J. Cancer 58: 825–831
Djordjevic MV, Fan J, Ferguson S, Hoffmann D . 1995 Carcinogenesis 16: 2015–2021
Djordjevic MV, Hoffmann D, Hoffmann I . 1997 Prev. Med. 26: 435–440
Djordjevic MV, Stellman SD, Zang E . 2000 J. Natl. Cancer Inst. 92: 106–111
Doll R, Peto R . 1976 Br. Med. J. 2: 1525–1536
Dunn BP, Vedal S, San RH, Kwan WF, Nelems B, Enarson DA, Stich HF . 1991 Int. J. Cancer 48: 485–492
Ebert RV, McNabb ME, McCusker KT, Snow SL . 1983 JAMA 250: 2840–2842
Ernster VL . 1996 Annu. Rev. Public Health 17: 97–114
Fischer S, Spiegelhalder B, Eisenbarth J, Preussmann R . 1990 Carcinogenesis 11: 723–730
Fischer S, Spiegelhalder B, Preussmann R . 1989 Carcinogenesis 10: 1511–1517
Gao YT, Blot WJ, Zheng W, Ershow AG, Hsu CW, Levin LI, Zhang R, Fraumeni Jr JF . 1987 Int. J. Cancer 40: 604–609
Grinberg-Funes RA, Singh VN, Perera FP, Bell DA, Young TL, Dickey C, Wang LW, Santella RM . 1994 Carcinogenesis 15: 2449–2454
Gritz ER, Rose JE, Jarvik ME . 1983 Pharmacol. Biochem. Behav. 18: 457–462
Haldorsen T, Grimsrud TK . 1999 Int. J. Epidemiol. 28: 1032–1036
Halpern MT, Gillespie BW, Warner KE . 1993 J. Natl. Cancer Inst. 85: 457–464
Harris CC, Genta VM, Frank AL, Kaufman DG, Barrett LA, McDowell EM, Trump BF . 1974 Nature 252: 68–69
Hartmann A, Blaszyk H, Kovach JS, Sommer SS . 1997 Trends Genet. 13: 27–33
Hecht SS . 1998 Chem. Res. Toxicol. 11: 559–603
Hecht SS . 1999a J. Natl. Cancer Inst. 91: 1194–1210
Hecht SS . 1999b Mutat. Res. 424: 127–142
Hecht SS, Carmella SG, Murphy SE, Akerkar S, Brunnemann KD, Hoffmann D . 1993 N. Engl. J. Med. 329: 1543–1546
Hegmann KT, Fraser AM, Keaney RP, Moser SE, Nilasena DS, Sedlars M, Higham-Gren L, Lyon JL . 1993 Epidemiology 4: 444–448
Hoffmann D, Hoffmann I . 1997 J. Toxicol. Environ. Health 50: 307–364
Hou SM, Yang K, Nyberg F, Hemminki K, Pershagen G, Lambert B . 1999 Carcinogenesis 20: 437–444
International Agency on the Research for Cancer. 1986 IARC monographs on the evaluation of the carcinogenic risk of chemicals to humans: tobacco smoking Vol 38: Lyon, France: IARC
Kaiser U, Hofmann J, Schilli M, Wegmann B, Klotz U, Wedel S, Virmani AK, Wollmer E, Branscheid D, Gazdar AF, Havemann K . 1996 Int. J. Cancer 67: 357–364
Kato S, Bowman ED, Harrington AM, Blomeke B, Shields PG . 1995 J. Natl. Cancer Inst. 87: 902–907
Kim JH, Stansbury KH, Walker NJ, Trush MA, Strickland PT, Sutter TR . 1998 Carcinogenesis 19: 1847–1853
Klein-Szanto AJ, Iizasa T, Momiki S, Garcia-Palazzo I, Caamano J, Metcalf R, Welsh J, Harris CC . 1992 Proc. Natl. Acad. Sci. USA 89: 6693–6697
Kondo K, Tsuzuki H, Sasa M, Sumitomo M, Uyama T, Monden Y . 1996 J. Surg. Oncol. 61: 20–26
Kure EH, Ryberg D, Hewer A, Phillips DH, Skaug V, Baera R, Haugen A . 1996 Carcinogenesis 17: 2201–2205
Lee PN . 1998 Stat. Meth. Med. Res. 7: 137–163
Lerman C, Caporaso N, Main D, Audrain J, Boyd NR, Bowman ED, Shields PG . 1998 Health Psychol. 17: 56–62
Lerman C, Caporaso NE, Main D, Audrain J, Bowman ED, Lockshin B, Boyd NR, Shields PG . 1999 Health Psychol. 18: 14–20
Levi F, La Vecchia C, Decarli A . 1987 Eur. J. Cancer Clin. Oncol. 23: 1025–1029
Lewis DF, Brantom PG, Ioannides C, Walker R, Parke DV . 1997 Drug Metab. Rev. 29: 1055–1078
Lodovici M, Akpan V, Giovannini L, Migliani F, Dolara P . 1998 Chem. Biol. Interact. 116: 199–212
Maclure M, Katz RB, Bryant MS, Skipper PL, Tannenbaum SR . 1989 Am. J. Public Health 79: 1381–1384
Mollerup S, Ryberg D, Hewer A, Phillips DH, Haugen A . 1999 Cancer Res. 59: 3317–3320
Mustonen R, Schoket B, Hemminki K . 1993 Carcinogenesis 14: 151–154
Nakachi K, Imai K, Hayashi S, Kawajiri K . 1993 Cancer Res. 53: 2994–2999
Nakachi K, Imai K, Hayashi S, Watanabe J, Kawajiri K . 1991 Cancer Res. 51: 5177–5180
NCI Expert Committee. 2000 The FTC cigarette test method for determining tar, nicotine and low yields of US cigarettes. Smoking and tobacco control monograph Washington, DC: US Department of Health pp. 238–247
Noble EP, St Jeor ST, Ritchie T, Syndulko K, St Jeor SC, Fitch RJ, Brunner RL, Sparkes RS . 1994 Med. Hypotheses 42: 257–260
Nyberg F, Isaksson I, Harris JR, Pershagen G . 1997 Epidemiology 8: 304–309
Okada T, Kawashima K, Fukushi S, Minakuchi T, Nishimura S . 1995 Pharmacogenetics 4: 333–340
Palmisano WA, Divine KK, Saccomanno G, Gilliland FD, Baylin SB, Herman JG, Belinsky SA . 2000 Cancer Res. 60: 5954–5958
Parsons WD, Carmella SG, Akerkar S, Bonilla LE, Hecht SS . 1998 Cancer Epidemiol. Biomarkers Prev. 7: 257–260
Pastorelli R, Guanci M, Cerri A, Negri E, La Vecchia C, Fumagalli F, Mezzetti M, Cappelli R, Panigalli T, Fanelli R, Airoldi L . 1998 Cancer Epidemiol. Biomarkers Prev. 7: 703–709
Peluso M, Airoldi L, Armelle M, Martone T, Coda R, Malaveille C, Giacomelli G, Terrone C, Casetta G, Vineis P . 1998 Cancer Epidemiol. Biomarkers Prev. 7: 341–346
Perera FP . 1987 J. Natl. Cancer Inst. 78: 887–898
Phillips DH, Hewer A, Martin CN, Garner RC, King MM . 1988 Nature 336: 790–792
Poli P, Buschini A, Spaggiari A, Rizzoli V, Carlo-Stella C, Rossi C . 1999 Toxicol. Lett. 108: 267–276
Prescott E, Osler M, Andersen PK, Hein HO, Borch-Johnsen K, Lange P, Schnohr P, Vestbo J . 1998 Int. J. Epidemiol. 27: 27–32
Rennard SI, Daughton D, Fujita J, Oehlerking MB, Dobson JR, Stahl MG, Robbins RA, Thompson AB . 1990 Eur. Respir. J. 3: 752–759
Repace JL, Lowrey AH . 1990 Risk Analysis 10: 27–37
Risch HA, Howe GR, Jain M, Burch JD, Holowaty EJ, Miller AB . 1993 Am. J. Epidemiol. 138: 281–293
Risch HA, Howe GR, Jain M, Burch JD, Holowaty EJ, Miller AB . 1994 Science 263: 1206–1208
Robertson IGC, Guthenberg C, Mannervik B, Jernstrom B . 1988 Polycarbon aromatic hydrocarbons Cooke M and Dennis AJ (eds) Columbus, OH: Batelle Press pp. 799–808
Rojas M, Alexandrov K, Cascorbi I, Brockmoller J, Likhachev A, Pozharisski K, Bouvier G, Auburtin G, Mayer L, Kopp-Schneider A, Roots I, Bartsch H . 1998 Pharmacogenetics 8: 109–118
Ronai ZA, Gradia S, Peterson LA, Hecht SS . 1993 Carcinogenesis 14: 2419–2422
Ryberg D, Hewer A, Phillips DH, Haugen A . 1994 Cancer Res. 54: 5801–5803
Ryberg D, Skaug V, Hewer A, Phillips DH, Harries LW, Wolf CR, Ogreid D, Ulvik A, Vu P, Haugen A . 1997 Carcinogenesis 18: 1285–1289
Sabol SZ, Nelson ML, Fisher C, Gunzerath L, Brody CL, Hu S, Sirota LA, Marcus SE, Greenberg BD, Lucas FR4, Benjamin J, Murphy DL, Hamer DH . 1999 Health Psychol. 18: 7–13
Schmid W . 1975 9–15
Schoket B, Phillips DH, Kostic S, Vincze I . 1998 Carcinogenesis 19: 841–846
Scott FM, Modali R, Lehman TA, Seddon M, Kelly K, Dempsey EC, Wilson V, Tockman MS, Mulshine JL . 1997 Clin. Cancer Res. 3: 479–482
Seto H, Ohkubo T, Kanoh T, Koike M, Nakamura K, Kawahara Y . 1993 Arch. Environ. Contam. Toxicol. 24: 498–503
Shields PG . 1998 Medical and workplace applications of biomarkers 253–255
Shields PG, Lerman C, Audrain J, Bowman ED, Main D, Boyd NR, Caporaso NE . 1998 Cancer Epidemiol. Biomarkers Prev. 7: 453–458
Shimada T, Hayes CL, Yamazaki H, Amin S, Hecht SS, Guengerich FP, Sutter TR . 1996 Cancer Res. 56: 2979–2984
Shopland DR, Eyre HJ, Pechacek TF . 1991 J. Natl. Cancer Inst. 83: 1142–1148
Shriver SP, Bourdeau HA, Gubish CT, Tirpak DL, Davis AL, Luketich JD, Siegfried JM . 2000 J. Natl. Cancer Inst. 92: 24–33
Sidney S, Tekawa IS, Friedman GD, Sadler MC, Tashkin DP . 1995 Arch. Intern. Med. 155: 727–732
Slebos RJ, Hruban RH, Dalesio O, Mooi WJ, Offerhaus GJ, Rodenhuis S . 1991 J. Natl. Cancer Inst. 83: 1024–1027
Smith TJ, Guo Z, Gonzalez FJ, Guengerich FP, Stoner GD, Yang CS . 1992 Cancer Res. 52: 1757–1763
Smith TJ, Stoner GD, Yang CS . 1995 Cancer Res. 55: 5566–5573
Sorsa M, Falck K, Heinonen T, Vainio H, Norppa H, Rimpela M . 1984 Environ. Res. 33: 312–321
Speit G, Hartmann A . 1999 Methods Mol. Biol. 113: 203–212
Spitz MR, Shi H, Yang F, Hudmon KS, Jiang H, Chamberlain RM, Amos CI, Wan Y, Cinciripini P, Hong WK, Wu Z . 1998 J. Natl. Cancer Inst. 90: 358–363
Stern SJ, Degawa M, Martin MV, Guengerich FP, Kaderlik RK, Ilett KF, Breau R, McGhee M, Montague D, Lyn-Cook B . 1993 J. Cell. Biochem. Suppl 17F: 129–137
Stockwell HG, Goldman AL, Lyman GH, Noss CI, Armstrong AW, Pinkham PA, Candelora EC, Brusa MR . 1992 J. Natl. Cancer Inst. 84: 1417–1422
Sunyer J, Munoz A, Peng Y, Margolick J, Chmiel JS, Oishi J, Kingsley L, Samet JM . 1996 Am. J. Epidemiol. 144: 734–741
Takagi Y, Osada H, Kuroishi T, Mitsudomi T, Kondo M, Niimi T, Saji S, Gazdar AF, Takahashi T, Minna JD, Takahashi T . 1998 Br. J. Cancer 77: 1568–1572
Tang D, Phillips DH, Stampfer M, Mooney LA, Hsu Y, Cho S, Tsai WY, Ma J, Cole KJ, She MN, Perera FP . 2001 Cancer Res. 61: 6708–6712
Tang D, Santella RM, Blackwood AM, Young TL, Mayer J, Jaretzki A, Grantham S, Tsai WY, Perera FP . 1995 Cancer Epidemiol. Biomarkers Prev. 4: 341–346
Tang DL, Rundle A, Warburton D, Santella RM, Tsai WY, Chiamprasert S, Hsu YZ, Perera FP . 1998 Carcinogenesis 19: 1949–1953
Thun MJ, Lally CA, Flannery JT, Calle EE, Flanders WD, Heath Jr CW . 1997 J. Natl. Cancer Inst. 89: 1580–1586
Tiano HF, Wang RL, Hosokawa M, Crespi C, Tindall KR, Langenbach R . 1994 Carcinogenesis 15: 2859–2866
Tricker AR, Ditrich C, Preussmann R . 1991 Carcinogenesis 12: 257–261
Tweedie RL, Mengersen KL . 1992 Br. J. Cancer 66: 700–705
Valkonen M, Kuusi T . 1998 Circulation 97: 2012–2016
van Delft JH, Baan RA, Roza L . 1998 Crit. Rev. Toxicol. 28: 477–510
Van Schooten FJ, Hillebrand MJ, Van Leeuwen FE, Lutgerink JT, van Zandwijk N, Jansen HM, Kriek E . 1990 Carcinogenesis 11: 1677–1681
Vineis P, Bartsch H, Caporaso N, Harrington AM, Kadlubar FF, Landi MT, Malaveille C, Shields PG, Skipper P, Talaska G . 1994 Nature 369: 154–156
Wada M, Bartram CR, Nakamura H, Hachiya M, Chen DL, Borenstein J, Miller CW, Ludwig L, Hansen-Hagge TE, Ludwig WD, Reiter A, Mizoguchii H, Koeffler HP . 1993 Blood 82: 3163–3169
Wiencke JK, Kelsey KT, Varkonyi A, Semey K, Wain JC, Mark E, Christiani DC . 1995 Cancer Res. 55: 4910–4914
Wingo PA, Ries LA, Giovino GA, Miller DS, Rosenberg HM, Shopland DR, Thun MJ, Edwards BK . 1999 J. Natl. Cancer Inst. 91: 675–690
Xue KX, Wang S, Ma GJ, Zhou P, Wu PQ, Zhang RF, Xu Z, Chen WS, Wang YQ . 1992 Int. J. Cancer 50: 702–705
Yakubovskaya MS, Spiegelman V, Luo FC, Malaev S, Salnev A, Zborovskaya I, Gasparyan A, Polotsky B, Machaladze Z, Trachtenberg AC . 1995 Int. J. Cancer 63: 810–814
Zang EA, Wynder EL . 1996 J. Natl. Cancer Inst. 88: 183–192
Zaridze DG, Safaev RD, Belitsky GA, Brunnemann KD, Hoffmann D . 1991 IARC Sci. Publ. 105: 485–488
Zeise L, Dunn A, Haroun L, Ting D, Windham G, Golub M, Waller K, Lipsett M, Shusterman D, Mann J, Wu A . 1997 Washington, DC: Environmental Protection Agency Report
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Shields, P. Molecular epidemiology of smoking and lung cancer. Oncogene 21, 6870–6876 (2002). https://doi.org/10.1038/sj.onc.1205832
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1205832
Keywords
This article is cited by
-
Associations between telomere attrition, genetic variants in telomere maintenance genes, and non-small cell lung cancer risk in the Jammu and Kashmir population of North India
BMC Cancer (2023)
-
Healthcare Prometrics in the Era of Redeployment
Journal of the Knowledge Economy (2022)
-
Genetic evaluation of the variants using MassARRAY in non-small cell lung cancer among North Indians
Scientific Reports (2021)
-
Association of newly identified genetic variant rs2853677 of TERT with non-small cell lung cancer and leukemia in population of Jammu and Kashmir, India
BMC Cancer (2019)
-
Major depression and enhanced molecular senescence abnormalities in young and middle-aged adults
Translational Psychiatry (2019)